Correspondence
- PMID: 39316834
- DOI: 10.1097/IAE.0000000000004265
Correspondence
References
-
- Boyer D, Hu A, Warrow D, et al. Lightsite III: 13-month efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative (dry) age-related macular degeneration using the LumiThera Valeda Light Delivery System. Retina 2024;44:487–497.
-
- Henein C, Steel DHW. Photobiomodulation for non-exudative age-related macular degeneration. Cochrane Database Syst Rev 2021;5:1–33.
-
- Markowitz SN, Devenyi RG, Munk MR, et al. A double-masked, randomized, sham-controlled, single-center study with photo-biomodulation for the treatment of dry age-related macular degeneration. Retina 2020;40:1471–1482.
-
- Burton B, Parodi MB, Jürgens I, et al. LIGHTSITE II Randomized Multicenter Trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration. Ophthalmol Ther 2023;12:953–968.
-
- Grisanti S, Bartz-Schmidt U, Heimann H, et al. Letter to the editor regarding “LIGHTSITE II Randomized Multicenter Trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration”. Ophthalmol Ther 2024;13:1051–1053.
LinkOut - more resources
Full Text Sources